{
     "PMID": "19162477",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090310",
     "LR": "20161025",
     "IS": "1464-3405 (Electronic) 0960-894X (Linking)",
     "VI": "19",
     "IP": "4",
     "DP": "2009 Feb 15",
     "TI": "A novel class of allosteric modulators of AMPA/Kainate receptors.",
     "PG": "1254-7",
     "LID": "10.1016/j.bmcl.2008.12.094 [doi]",
     "AB": "The rapid hydrolysis in vivo of IDRA21 to 2-amino-5-chlorobenzensulfonamide has been demonstrated by microdialysis experiments. The IDRA21 metabolite possess in vitro a biological activity similar to that of IDRA21 itself. Taking 2-amino-5-chlorobenzensulfonamide as lead compound, a novel class of AMPAR positive allosteric modulators has been prepared.",
     "FAU": [
          "Cannazza, Giuseppe",
          "Jozwiak, Krzysztof",
          "Parenti, Carlo",
          "Braghiroli, Daniela",
          "Carrozzo, Marina M",
          "Puia, Giulia",
          "Losi, Gabriele",
          "Baraldi, Mario",
          "Lindner, Wolfgang",
          "Wainer, Irving W"
     ],
     "AU": [
          "Cannazza G",
          "Jozwiak K",
          "Parenti C",
          "Braghiroli D",
          "Carrozzo MM",
          "Puia G",
          "Losi G",
          "Baraldi M",
          "Lindner W",
          "Wainer IW"
     ],
     "AD": "Department of Pharmaceutical Science, University of Modena e Reggio Emilia, Via Campi 183, 41100 Modena, Italy. giuseppe.cannazza@unimo.it",
     "LA": [
          "eng"
     ],
     "GR": [
          "Z01 AG000295-06/Intramural NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Intramural"
     ],
     "DEP": "20081230",
     "PL": "England",
     "TA": "Bioorg Med Chem Lett",
     "JT": "Bioorganic & medicinal chemistry letters",
     "JID": "9107377",
     "RN": [
          "0 (2-amino-5-chlobenzensulfonamide)",
          "0 (Benzothiadiazines)",
          "0 (Receptors, AMPA)",
          "0 (Receptors, Kainic Acid)",
          "0 (Sulfonamides)",
          "22503-72-6 (IDRA 21)",
          "98-10-2 (benzenesulfonamide)"
     ],
     "SB": "IM",
     "MH": [
          "Administration, Oral",
          "Animals",
          "Benzothiadiazines/chemistry/*pharmacology",
          "Combinatorial Chemistry Techniques",
          "Hippocampus/drug effects",
          "*Models, Molecular",
          "Molecular Structure",
          "Rats",
          "Receptors, AMPA/*drug effects",
          "Receptors, Kainic Acid/*drug effects",
          "Sulfonamides/*chemical synthesis/chemistry/*pharmacology"
     ],
     "PMC": "PMC2656388",
     "MID": [
          "NIHMS94127"
     ],
     "EDAT": "2009/01/24 09:00",
     "MHDA": "2009/03/11 09:00",
     "CRDT": [
          "2009/01/24 09:00"
     ],
     "PHST": [
          "2008/11/16 00:00 [received]",
          "2008/12/16 00:00 [revised]",
          "2008/12/16 00:00 [accepted]",
          "2009/01/24 09:00 [entrez]",
          "2009/01/24 09:00 [pubmed]",
          "2009/03/11 09:00 [medline]"
     ],
     "AID": [
          "S0960-894X(08)01592-8 [pii]",
          "10.1016/j.bmcl.2008.12.094 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Bioorg Med Chem Lett. 2009 Feb 15;19(4):1254-7. doi: 10.1016/j.bmcl.2008.12.094. Epub 2008 Dec 30.",
     "term": "hippocampus"
}